INDOCO / NSE / Biotechnology & Drugs
Indoco Remedies
1Y Price Trend
Key Information
Recommendations
RatingSell
Target High348.1
Target Low163.7
Target Mean3.5
Target Median12.5
Risk Metrics
Overall RiskHigh risk
Board Risk47.23
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Indoco Remedies Share Price Today Up 14% Equitymaster
Indoco Remedies Ltd Upgraded to Sell on Improved Valuation Amid Mixed Financials Markets Mojo
Indoco Remedies Ltd is Rated Strong Sell Markets Mojo
Indoco's formulation plant at Baddi receives EU GMP certification Indian Pharma Post
Indoco Remedies Ltd Opens 6.01% Higher in Sharp Gap Up, But Can the Technicals Support It? Markets Mojo
Indoco Remedies shines on getting EU GMP certification for OSD facility in Himachal Pradesh Investment Guru India
Indoco Remedies climbs after Baddi plant secures EU GMP certification; ICICI Prudential MF buys 1.47% stake Business Standard
Buzzing Stocks: Indoco Remedies jumps 4% on EU GMP nod; Bata India slips 3% after weak Q4 Moneycontrol.com
© SharekeyX | Rusaka Technologies 2024-2026

